BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 9164976)

  • 41. Expression and cytokine regulation of glucocorticoid receptors in Kaposi's sarcoma.
    Guo WX; Antakly T; Cadotte M; Kachra Z; Kunkel L; Masood R; Gill P
    Am J Pathol; 1996 Jun; 148(6):1999-2008. PubMed ID: 8669484
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of AIDS-associated Kaposi's sarcoma cell growth by DAB389-interleukin 6.
    Masood R; Lunardi-Iskandar Y; Jean LF; Murphy JR; Waters C; Gallo RC; Gill P
    AIDS Res Hum Retroviruses; 1994 Aug; 10(8):969-75. PubMed ID: 7811548
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differential activation of the extracellular signal-regulated kinase, Jun kinase and Janus kinase-Stat pathways by oncostatin M and basic fibroblast growth factor in AIDS-derived Kaposi's sarcoma cells.
    Faris M; Ensoli B; Stahl N; Yancopoulos G; Nguyen A; Wang S; Nel AE
    AIDS; 1996 Apr; 10(4):369-78. PubMed ID: 8728040
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Human herpesvirus 8-derived viral IL-6 induces PTX3 expression in Kaposi's sarcoma cells.
    Klouche M; Brockmeyer N; Knabbe C; Rose-John S
    AIDS; 2002 May; 16(8):F9-18. PubMed ID: 12004288
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Influence of interleukin-6 (IL-6) dimerization on formation of the high affinity hexameric IL-6.receptor complex.
    Ward LD; Hammacher A; Howlett GJ; Matthews JM; Fabri L; Moritz RL; Nice EC; Weinstock J; Simpson RJ
    J Biol Chem; 1996 Aug; 271(33):20138-44. PubMed ID: 8702737
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antiproliferative effects of enediynes on AIDS-derived Kaposi's sarcoma cells.
    Corbeil J; Richman DD; Wrasidlo W; Nicolaou KC; Looney DJ
    Cancer Res; 1994 Aug; 54(16):4270-3. PubMed ID: 8044770
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Heterogeneity of spindle cells in Kaposi's sarcoma: comparison of cells in lesions and in culture.
    Kaaya EE; Parravicini C; Ordonez C; Gendelman R; Berti E; Gallo RC; Biberfeld P
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Nov; 10(3):295-305. PubMed ID: 7552491
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cultured AIDS-related Kaposi's sarcoma cells retain a proliferative bioenergetic profile but demonstrate reduced cytoprotective capabilities.
    Mallery SR; Ng-Bautista CL; Lantry LE; Ness GM; Hegtvedt AK; Lazo A; Bailer RT; Hout BL; Stephens RE; Brierley GP
    J Cell Biochem; 1994 Dec; 56(4):568-81. PubMed ID: 7890815
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Targeted gene delivery to Kaposi's sarcoma cells via the fibroblast growth factor receptor.
    Goldman CK; Rogers BE; Douglas JT; Sosnowski BA; Ying W; Siegal GP; Baird A; Campain JA; Curiel DT
    Cancer Res; 1997 Apr; 57(8):1447-51. PubMed ID: 9108444
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Functional significance of novel neurotrophin-1/B cell-stimulating factor-3 (cardiotrophin-like cytokine) for human myeloma cell growth and survival.
    Burger R; Bakker F; Guenther A; Baum W; Schmidt-Arras D; Hideshima T; Tai YT; Shringarpure R; Catley L; Senaldi G; Gramatzki M; Anderson KC
    Br J Haematol; 2003 Dec; 123(5):869-78. PubMed ID: 14632778
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Astrocyte differentiation of fetal neuroepithelial cells by interleukin-11 via activation of a common cytokine signal transducer, gp130, and a transcription factor, STAT3.
    Yanagisawa M; Nakashima K; Arakawa H; Ikenaka K; Yoshida K; Kishimoto T; Hisatsune T; Taga T
    J Neurochem; 2000 Apr; 74(4):1498-504. PubMed ID: 10737606
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Increased expression of fibroblast growth factors (FGFs) and their receptor by protamine and suramin on Kaposi's sarcoma-derived cells.
    Huang YQ; Li JJ; Nicolaides A; Zhang WG; Friedman-Kien AE
    Anticancer Res; 1993; 13(4):887-90. PubMed ID: 8394679
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Consensus-interferon and platelet-derived growth factor adversely regulate proliferation and migration of Kaposi's sarcoma cells by control of c-myc expression.
    Köster R; Blatt LM; Streubert M; Zietz C; Hermeking H; Brysch W; Stürzl M
    Am J Pathol; 1996 Dec; 149(6):1871-85. PubMed ID: 8952524
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment of AIDS-related Kaposi's sarcoma.
    Northfelt DW; Kahn JO; Volberding PA
    Hematol Oncol Clin North Am; 1991 Apr; 5(2):297-310. PubMed ID: 2022595
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Kaposi's sarcoma cells express the macrophage-associated antigen mannose receptor and develop in peripheral blood cultures of Kaposi's sarcoma patients.
    Uccini S; Sirianni MC; Vincenzi L; Topino S; Stoppacciaro A; Lesnoni La Parola I; Capuano M; Masini C; Cerimele D; Cella M; Lanzavecchia A; Allavena P; Mantovani A; Baroni CD; Ruco LP
    Am J Pathol; 1997 Mar; 150(3):929-38. PubMed ID: 9060831
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Protein kinase C delta associates with the interleukin-6 receptor subunit glycoprotein (gp) 130 via Stat3 and enhances Stat3-gp130 interaction.
    Novotny-Diermayr V; Zhang T; Gu L; Cao X
    J Biol Chem; 2002 Dec; 277(51):49134-42. PubMed ID: 12361954
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The designer cytokine hyper-interleukin-6 is a potent activator of STAT3-dependent gene transcription in vivo and in vitro.
    Rakemann T; Niehof M; Kubicka S; Fischer M; Manns MP; Rose-John S; Trautwein C
    J Biol Chem; 1999 Jan; 274(3):1257-66. PubMed ID: 9880494
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Insulin-like growth factor-I receptor activity is essential for Kaposi's sarcoma growth and survival.
    Catrina SB; Lewitt M; Massambu C; Dricu A; Grünler J; Axelson M; Biberfeld P; Brismar K
    Br J Cancer; 2005 Apr; 92(8):1467-74. PubMed ID: 15812560
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of constitutive cytokine release in high and low histologic grade AIDS-related Kaposi's sarcoma cell strains and in sera from HIV+/KS+ and HIV+/KS- patients.
    Bailer RT; Lazo A; Ng-Bautista CL; Hout BL; Ness GM; Hegtvedt AK; Blakeslee JR; Stephens RE; Brierley GP; Mallery SR
    J Interferon Cytokine Res; 1995 May; 15(5):473-83. PubMed ID: 7648450
    [TBL] [Abstract][Full Text] [Related]  

  • 60. STAT3 is constitutively activated in Hodgkin cell lines.
    Kube D; Holtick U; Vockerodt M; Ahmadi T; Haier B; Behrmann I; Heinrich PC; Diehl V; Tesch H
    Blood; 2001 Aug; 98(3):762-70. PubMed ID: 11468177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.